Top Markets
Coin of the day
Kazia Therapeutics Limited Kazia Therapeutics Limited

Kazia Therapeutics Limited

KZA
Rang în acțiuni #35840
Kazia Therapeutics Limited is a biotechnology firm specializing in oncology,... Kazia Therapeutics Limited is a biotechnology firm specializing in oncology, committed to developing innovative therapies for cancer. Its flagship product candidate, Paxalisib, is a brain-penetrant small molecule that inhibits the PI3K/Akt/mTor pathway and is currently being investigated as a potential treatment for glioblastoma. Additionally, the company is progressing EVT801, an investigational new drug aimed at combating various types of cancer. Established in 1994 and headquartered in Sydney, Australia, the entity was formerly known as Novogen Limited before adopting the name Kazia Therapeutics Limited in November 2017.
Preț acțiune
$0.05207079
Ultima sincronizare: 2023-11-15
Capitalizare de piață
$3.38M
Schimbare (1 zi)
0.13%
Schimbare (1 an)
0.00%
Țară
AU
Tranzacționează Kazia Therapeutics Limited (KZA)

Categorie

Istoric al prețului acțiunii pentru Kazia Therapeutics Limited (KZA)
Cel mai mare preț de închidere: $0.05 pe 2023-11-01

Cel mai mic preț de închidere: $2.34 pe 1994-09-01
Istoric al prețului acțiunii pentru Kazia Therapeutics Limited din 1994 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2023 -14.41%
2022 -93.21%
2021 -12.26%
2020 134.56%
2019 60.49%
2018 -10.55%
2017 -54.36%
2016 -26.11%
2015 4.87%
2014 -53.60%
2013 40.89%
2012 29.78%
2011 -12.03%
2010 -76.36%
2009 -1.22%
2008 -56.70%
2007 -44.36%
2006 -47.25%
2005 -15.26%
2004 -19.24%
2003 269.42%
2002 32.67%
2001 -37.00%
2000 -7.16%
1999 14.60%
1998 11.28%
1997 0.36%
1996 133.15%
1995 54.37%
1994 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE